MBOT - ステムセルズ (Microbot Medical Inc. )

MBOTのニュース

   Microbot Medical falls on $1.5M registered direct offering  2023/06/02 17:49:26 Seeking Alpha
Microbot Medical Inc. (MBOT) lost ~14% on Friday after aannounicing agreements to raise $1.5M in gross proceeds as part of a registered direct offering. Read more here.
   Microbot Medical Announces $1.5 Million Registered Direct Offering  2023/06/02 16:39:02 Investing.com
https://www.investing.com/news/assorted/microbot-medical-announces-15-million-registered-direct-offering-432SI-3097328
   Microbot Medical Announces $1.5 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules  2023/06/02 16:36:53 Benzinga
HINGHAM, Mass., June 02, 2023 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (NASDAQ: MBOT ) today announced that it has entered into definitive agreements for the purchase and sale of 701,756 shares of the Company''s common stock at a purchase price of $2.1375 per share of common stock in a registered direct offering priced at-the-market under Nasdaq rules. In addition, in a concurrent private placement, the Company will issue unregistered series C preferred investment options. The series C preferred investment options to purchase up to 350,878 shares of common stock have an exercise price of $2.075 per share and are immediately exercisable for a period of five and one-half years following issuance. The closing of the registered direct offering and the concurrent private placement is expected to occur on or about June 6, 2023, subject to the satisfaction of customary closing conditions. H.C. Wainwright & Co. is acting as the exclusive placement agent for the offerings. The gross proceeds to the Company from the offerings are expected to be $1.5 million, before deducting the placement agent''s fees and other offering expenses payable by the Company.
   Microbot Medical Announces $1.5 Million Registered Direct  2023/06/02 16:36:00 businessfortnight.com
HINGHAM, Mass., June 02, 2023 (GLOBE NEWSWIRE) — Microbot Medical Inc. (Nasdaq: MBOT) today announced that it has entered into definitive agreements for the purchase and sale of 701,756 shares of the Company’s common stock at a purchase price of $2.1375 per share of common stock in a registered direct offering priced at-the-market under Nasdaq […] The post Microbot Medical Announces $1.5 Million Registered Direct appeared first on Businessfortnight .
   Microbot Medical Announces $1.5 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules  2023/06/02 16:36:00 GlobeNewswire
HINGHAM, Mass., June 02, 2023 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) today announced that it has entered into definitive agreements for the purchase and sale of 701,756 shares of the Company’s common stock at a purchase price of $2.1375 per share of common stock in a registered direct offering priced at-the-market under Nasdaq rules. In addition, in a concurrent private placement, the Company will issue unregistered series C preferred investment options. The series C preferred investment options to purchase up to 350,878 shares of common stock have an exercise price of $2.075 per share and are immediately exercisable for a period of five and one-half years following issuance. The closing of the registered direct offering and the concurrent private placement is expected to occur on or about June 6, 2023, subject to the satisfaction of customary closing conditions.
   Gerry O''Sullivan, the Latest Member to Join Microbot Medical''s Scientific Advisory Board, to Leverage Extensive Interventional Radiology Experience to Progress the LIBERTY® Robotic System Through Regulatory, Clinical and Commercialization Phases  2023/03/23 13:00:00 Benzinga
Widely Published Interventional Radiologist Has Earned Well-Regarded Reputation Working with Prestigious Medical Centers in the U.S. and Europe The addition of Professor O''Sullivan, the Clinical Director of Radiology for the Galway Clinic in Ireland , E xpands the Company''s EU P resence. HINGHAM, Mass., March 23, 2023 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (NASDAQ: MBOT ) continues to receive global interest from interventional radiologists due to the gap in new innovative technology currently available on the market today. Microbot Medical, the company developing the LIBERTY ® Robotic System, the first single-use endovascular robotic system, today announced that Professor Gerry O''Sullivan, a key opinion leader (KOL) from Ireland, has joined the Company''s Scientific Advisory Board (SAB). The Company believes the combination of his academic and medical experience will be invaluable while it seeks to establish Centers of Excellence throughout the U.S. and Europe in preparation for human clinical trials.
   Microbot Medical Launches Presence in UK  2023/03/16 13:03:04 Investing.com
https://www.investing.com/news/assorted/microbot-medical-launches-presence-in-uk-432SI-3032465
   Microbot Medical Launches Presence in the United Kingdom as Highly Accomplished Consultant Interventional Radiologist Professor Mark W. Little Joins its Scientific Advisory Board as Efforts to Commercialize the LIBERTY Robotic System Continue to Accelerat  2023/03/16 13:00:00 Wallstreet:Online
Internationally Recognized Academic Leader Awarded the National Institute for Health Research (NIHR) Research Rising Star Award, and Cardiovascular and Interventional Radiology (CVIR) Editors Medal HINGHAM, Mass., March 16, 2023 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), which is rapidly scaling up its internal capabilities with globally renowned members joining its Scientific
   Microbot Medical''s Remote Controller for the LIBERTY® Robotic System Receives Design Patent Allowance in Japan  2023/02/23 13:00:00 Benzinga
Allows Endovascular Procedure to be Performed from the Cath-Lab Control Room, Potentially Minimizing Radiation Exposure and Reducing Physical Strain for the Healthcare Providers Design Patent Complements Existing U.S. and European Design Patents as Feedback During Recent Meetings Continues to Support a Positive User Experience HINGHAM, Mass., Feb. 23, 2023 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (NASDAQ: MBOT ), announced that Japan is the most recent global jurisdiction to recognize the unique interface design of the LIBERTY ® Robotic System''s remote controller. The design patent, which was issued by the Japan Patent Office (JPO), complements similar design patent allowances in the U.S. and Europe, further strengthening the Company''s global intellectual property (IP) portfolio. "We believe the ability to perform an endovascular procedure remotely, while reducing radiation exposure and the physical strain due to wearing a lead vest for an extensive period of time, is a major benefit to the physician and patients," commented Dr.
   Microbot Medical Announces the Participation of a Key Opinion Leader in the Endovascular Robotics Space at the Next "Access-Ability Live by MBOT" Webinar Series  2022/12/14 13:30:00 Benzinga
The Webinar, Which is Suitable to All Stakeholders Interested in the Future of Endovascular Robotics, Will be Held on Wednesday, December 21, 2022, at 1:00pm ET Dr. Ripal Gandhi, a Renowned Miami-Based Interventional Oncologist, Will Share His Personal Experiences Having Completed Over 100 Endovascular Robotic Surgical Procedures HINGHAM, Mass., Dec. 14, 2022 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (NASDAQ: MBOT ), the developer of the LIBERTY® Robotic System, the first fully disposable endovascular robotic system, announced that following the success of the first episode of its newly launched "Access-Ability Live by MBOT," the next episode which is geared toward all stakeholders interested in the endovascular robotic space, will be held on Wednesday, December 21, 2022 at 1:00pm ET, and hosted by the Company''s Chief Medical Officer, Dr. Eyal Morag. Dr. Morag''s guest speaker will be Dr. Ripal Gandhi, an interventional oncologist and a member of the Miami Cardiac & Vascular Institute and Miami Cancer Institute physician team where he specializes in minimally invasive treatments for peripheral vascular disease, cancer, and other diseases, and has a history of being an innovator in the Interventional Robotics field, specifically in the Endovascular space.
   Microbot Medical to Review Recent Progress During Needham''s Virtual Healthcare Conference  2022/04/11 21:30:00 Benzinga
HINGHAM, Mass., April 11, 2022 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (NASDAQ: MBOT ), announced it will be presenting at the Annual Needham Virtual Healthcare Conference. Harel Gadot, Chairman, President and CEO will provide an overview of the Company and recent progress on Tuesday, April 12 th at 8:45am ET. The live and archived replays of the presentation may be accessed via the ‘Investors'' section, under ‘Presentation + Resources'' of the Company''s website at www.microbotmedical.com . About Microbot Medical Microbot Medical Inc. (NASDAQ: MBOT ) is a pre-clinical medical device company that specializes in transformational micro-robotic technologies, focused primarily on both natural and artificial lumens within the human body. Microbot''s current proprietary technological platforms provide the foundation for the development of … Full story available on Benzinga.com
   Microbot Medical promotes Rachel Vaknin to CFO  2022/04/06 20:09:36 Seeking Alpha
Microbot Medical (MBOT) has promoted Rachel Vaknin as its Chief Financial Officer ((CFO)), effective Apr. 1, 2022.Ms
   Thinking about buying stock in Exterran Corp, Microbot Medical, Nordstrom, Telefonica S.A., or Assertio Holdings?  2022/01/24 13:30:00 Benzinga
NEW YORK , Jan. 24, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for EXTN, MBOT, JWN, TEF, and ASRT. Full story available on Benzinga.com
   Microbot Medical, CymaBay lead healthcare gainers; Aptorum, G Medical among losers  2022/01/21 15:01:36 Seeking Alpha
Microbot Medical (MBOT) +10%. CymaBay Therapeutics (CBAY) +9%. Aptorum (APM) -13%. G Medical Innovations (GMVD) -11%.
   Microbot Medical''s Stryker Collaboration Makes This An Intriguing High Flier  2022/01/06 15:48:34 Seeking Alpha

calendar